UBS Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Buy |
161,900
+68,288
| +73% | +$294K | ﹤0.01% | 4607 |
|
|
2025
Q1 | $350K | Buy |
93,612
+83,893
| +863% | +$314K | ﹤0.01% | 4919 |
|
|
2024
Q4 | $98.6K | Buy |
9,719
+754
| +8% | +$7.65K | ﹤0.01% | 5670 |
|
|
2024
Q3 | $112K | Sell |
8,965
-414
| -4% | -$5.15K | ﹤0.01% | 5087 |
|
|
2024
Q2 | $122K | Sell |
9,379
-7,617
| -45% | -$99.2K | ﹤0.01% | 4912 |
|
|
2024
Q1 | $385K | Sell |
16,996
-13,483
| -44% | -$305K | ﹤0.01% | 4274 |
|
|
2023
Q4 | $395K | Sell |
30,479
-29,964
| -50% | -$389K | ﹤0.01% | 4146 |
|
|
2023
Q3 | $1.21M | Buy |
60,443
+31,269
| +107% | +$629K | ﹤0.01% | 2941 |
|
|
2023
Q2 | $783K | Buy |
29,174
+18,345
| +169% | +$493K | ﹤0.01% | 3484 |
|
|
2023
Q1 | $632K | Sell |
10,829
-24,055
| -69% | -$1.4M | ﹤0.01% | 3536 |
|
|
2022
Q4 | $1.78M | Buy |
34,884
+27,381
| +365% | +$1.4M | ﹤0.01% | 2658 |
|
|
2022
Q3 | $614K | Sell |
7,503
-13,666
| -65% | -$1.12M | ﹤0.01% | 3209 |
|
|
2022
Q2 | $1.43M | Sell |
21,169
-13,395
| -39% | -$906K | ﹤0.01% | 2612 |
|
|
2022
Q1 | $3.82M | Buy |
34,564
+16,764
| +94% | +$1.85M | ﹤0.01% | 2139 |
|
|
2021
Q4 | $1.72M | Sell |
17,800
-22,766
| -56% | -$2.2M | ﹤0.01% | 2997 |
|
|
2021
Q3 | $3.54M | Buy |
40,566
+20,997
| +107% | +$1.83M | ﹤0.01% | 2309 |
|
|
2021
Q2 | $3.03M | Buy |
19,569
+9,834
| +101% | +$1.52M | ﹤0.01% | 2401 |
|
|
2021
Q1 | $1.54M | Buy |
9,735
+5,149
| +112% | +$813K | ﹤0.01% | 2988 |
|
|
2020
Q4 | $1.07M | Sell |
4,586
-8,989
| -66% | -$2.09M | ﹤0.01% | 3109 |
|
|
2020
Q3 | $2.97M | Buy |
13,575
+4,620
| +52% | +$1.01M | ﹤0.01% | 2104 |
|
|
2020
Q2 | $2.54M | Buy |
8,955
+8,467
| +1,735% | +$2.41M | ﹤0.01% | 2099 |
|
|
2020
Q1 | $141K | Sell |
488
-534
| -52% | -$154K | ﹤0.01% | 4149 |
|
|
2019
Q4 | $294K | Sell |
1,022
-12,561
| -92% | -$3.61M | ﹤0.01% | 4329 |
|
|
2019
Q3 | $1.96M | Buy |
13,583
+13,402
| +7,404% | +$1.93M | ﹤0.01% | 2621 |
|
|
2019
Q2 | $16K | Hold |
181
| – | – | ﹤0.01% | 5891 |
|
|
2019
Q1 | $16K | Sell |
181
-14,269
| -99% | -$1.26M | ﹤0.01% | 5653 |
|
|
2018
Q4 | $2.03M | Buy |
14,450
+13,497
| +1,416% | +$1.9M | ﹤0.01% | 2427 |
|
|
2018
Q3 | $243K | Buy |
953
+315
| +49% | +$80.3K | ﹤0.01% | 4103 |
|
|
2018
Q2 | $163K | Sell |
638
-671
| -51% | -$171K | ﹤0.01% | 4239 |
|
|
2018
Q1 | $264K | Buy |
1,309
+1,157
| +761% | +$233K | ﹤0.01% | 3819 |
|
|
2017
Q4 | $21K | Sell |
152
-738
| -83% | -$102K | ﹤0.01% | 5548 |
|
|
2017
Q3 | $147K | Buy |
890
+645
| +263% | +$107K | ﹤0.01% | 4204 |
|
|
2017
Q2 | $33K | Buy |
245
+152
| +163% | +$20.5K | ﹤0.01% | 5026 |
|
|
2017
Q1 | $18K | Sell |
93
-64
| -41% | -$12.4K | ﹤0.01% | 5289 |
|
|
2016
Q4 | $22K | Sell |
157
-16
| -9% | -$2.24K | ﹤0.01% | 5516 |
|
|
2016
Q3 | $26K | Buy |
173
+53
| +44% | +$7.97K | ﹤0.01% | 5184 |
|
|
2016
Q2 | $12K | Sell |
120
-4
| -3% | -$400 | ﹤0.01% | 5789 |
|
|
2016
Q1 | $17K | Sell |
124
-220
| -64% | -$30.2K | ﹤0.01% | 5484 |
|
|
2015
Q4 | $68K | Buy |
344
+313
| +1,010% | +$61.9K | ﹤0.01% | 4521 |
|
|
2015
Q3 | $5K | Sell |
31
-74
| -70% | -$11.9K | ﹤0.01% | 6277 |
|
|
2015
Q2 | $43K | Sell |
105
-5,778
| -98% | -$2.37M | ﹤0.01% | 4869 |
|
|
2015
Q1 | $2.7M | Sell |
5,883
-6,500
| -52% | -$2.98M | ﹤0.01% | 2070 |
|
|
2014
Q4 | $6.95M | Buy |
+12,383
| New | +$6.95M | ﹤0.01% | 1381 |
|